PAREXEL International, Early Phase Clinical Unit - Los Angeles — Glendale, California

PAREXEL International, Early Phase Clinical Unit - Los Angeles is a clinical research site located in Glendale, California, United States 91206.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

PAREXEL International, Early Phase Clinical Unit - Los Angeles has participated in 1 clinical trials.

Therapeutic areas: Healthy.

Sponsors: Seagen Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Glendale

Browse all research sites in California · View every site in Glendale

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for PAREXEL International, Early Phase Clinical Unit - Los Angeles?

PAREXEL International, Early Phase Clinical Unit - Los Angeles has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has PAREXEL International, Early Phase Clinical Unit - Los Angeles conducted?

PAREXEL International, Early Phase Clinical Unit - Los Angeles has 1 clinical trials on record. Their work covers Healthy.

Is PAREXEL International, Early Phase Clinical Unit - Los Angeles accredited by Crixeo Clinical Trials?

PAREXEL International, Early Phase Clinical Unit - Los Angeles has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about PAREXEL International, Early Phase Clinical Unit - Los Angeles?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.